Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis

ClinicalTrials.gov ID: NCT00453401

Public ClinicalTrials.gov record NCT00453401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Safety, Pharmacokinetics, and Efficacy of NB-001 (0.1%, 0.3%, 0.5%) in Subjects With Recurrent Herpes Labialis

Study identification

NCT ID
NCT00453401
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NanoBio Corporation
Industry
Enrollment
1,000 participants

Conditions and interventions

Interventions

  • NB-001 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2007
Primary completion
Nov 30, 2007
Completion
Nov 30, 2007
Last update posted
May 29, 2008

2007

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
Medical Affiliated Research Center, Inc. Huntsville Alabama 35801
Advanced Clinical Research Institute Anaheim California 92801
Westlake Medical Research Westlake Village California 91361
Front Range Clinical Research Wheat Ridge Colorado 80033
The Savin Center, PC New Haven Connecticut 06511
Clinical Research of West Florida Clearwater Florida 33765
Clinical Physiology Associates Fort Myers Florida 33916
Suncoast Clinical Research New Port Richey Florida 34652
Advanced Clinical Research, Inc. Boise Idaho 83704
DermResearch, PLCC Louisville Kentucky 40217
MI Center for Skin Care Research Clinton Township Michigan 48038
Academic Dermatology Associates Albuquerque New Mexico 87106-5239
Wake Research Associates, LLM Raleigh North Carolina 27612
Westover Heights Clinic Portland Oregon 97210
Lederach Family Medicine Harleysville Pennsylvania 19438
Omega Medical Research Warwick Rhode Island 02888
Okatie Research Center, LLC Beaufort South Carolina 29902
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
Benchmark Research Austin Texas 78705
DermResearch Inc. Austin Texas 78759
J&S Studies Inc. Bryan Texas 77802
Dermatology Treatment & Research Center Dallas Texas 75230
Research Across America Dallas Texas 75234
R/D Clinical Research, Inc Lake Jackson Texas 77566
South Valley Dermatology Center West Jordan Utah 84088
New River Valley Research Institute Christiansburg Virginia 24073
Wenatchee Valley Medical Center Wenatchee Washington 98801
Advanced Healthcare Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00453401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2008 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00453401 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →